Search

everythinglearnresearchcommunity

for

Search:↓

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Cromolyn sodium oleate gel is more effective and safer for treating atopic dermatitis than dexamethasone.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Tofacitinib taken by mouth helps treat hair loss in children.

Reversing female hair loss.

A medication for skin rash also unexpectedly treated hair loss in a patient.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.